Torrent Pharmaceuticals' stock is trading positively at Rs. 3431.25, marking a gain of 21.50 points or 0.63% from its previous close of Rs. 3409.75 on the BSE. The stock opened at Rs. 3405.40, reaching a high of Rs. 3443.00 and a low of Rs. 3397.60, with 654 shares exchanged so far.

The company, part of the BSE group 'A', with a face value of Rs. 5, hit a 52-week high of Rs. 3574.00 on August 30, 2024, and a 52-week low of Rs. 1822.80 on October 25, 2023. Over the last week, the stock has fluctuated between Rs. 3520.00 and Rs. 3365.00. Torrent Pharmaceuticals' current market capitalization stands at Rs. 116019.10 crore.

The company’s promoters hold 71.25% of shares, while institutional and non-institutional investors own 21.49% and 7.26%, respectively.

Torrent Pharmaceuticals has formed a wholly-owned subsidiary, Torrent Pharmaceuticals Chile SpA, on September 25, 2024, to provide business support within Chile. Torrent Pharmaceuticals is the flagship company of the Torrent Group, known for its leadership in cardiovascular and central nervous system treatments, with additional expertise in gastro-intestinal, diabetology, anti-infective, and pain management sectors.